PF-08046052

DB22647InvestigationalProtein Based Therapies

PF-08046052 is under investigation in clinical trial NCT05983133 (A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors).

Code names
LAVA-1223 · PF-08046052 · SGN-EGFRd2

What you can answer from here — as of December 21, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of PF-08046052, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In